Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Mehrangiz Dezhbord, Seong Ho Kim, Soree Park, Da Rae Lee, Nayeon Kim, Juhee Won, Ah Ram Lee, Dong-Sik Kim, Kyun-Hwan Kim

Clin Mol Hepatol. 2024;30(3):539-560. Published online May 14, 2024

DOI: https://doi.org/10.3350/cmh.2024.0060

View: 1161 Download: 169

Neung Hwa Park, M.D., Young-Hwa Chung, M.D.

Clin Mol Hepatol. 2007;13(3):320-340. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.320

View: 6362 Download: 94 Crossref: 11

Jung Hyun Park

Clin Mol Hepatol. 2004;10(4):248-259.

View: 2686 Download: 28

Mehrangiz Dezhbord, Kyun-Hwan Kim

Received July 3, 2024 Accepted July 8, 2024

DOI: https://doi.org/10.3350/cmh.2024.0515 [Accepted]

View: 124 Download: 23

1 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5413	MAFLD: How is it different from NAFLD?
Viewed By 5222	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5101	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4732	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search